廣告
香港股市 已收市
  • 恒指

    17,651.15
    +366.61 (+2.12%)
     
  • 國指

    6,269.76
    +149.39 (+2.44%)
     
  • 上證綜指

    3,088.64
    +35.74 (+1.17%)
     
  • 滬深300

    3,584.27
    +53.99 (+1.53%)
     
  • 美元

    7.8282
    +0.0004 (+0.01%)
     
  • 人民幣

    0.9251
    +0.0008 (+0.09%)
     
  • 道指

    38,085.80
    -375.12 (-0.98%)
     
  • 標普 500

    5,048.42
    -23.21 (-0.46%)
     
  • 納指

    15,611.76
    -100.99 (-0.64%)
     
  • 日圓

    0.0497
    -0.0004 (-0.80%)
     
  • 歐元

    8.3873
    -0.0109 (-0.13%)
     
  • 英鎊

    9.7910
    -0.0010 (-0.01%)
     
  • 紐約期油

    84.14
    +0.57 (+0.68%)
     
  • 金價

    2,356.80
    +14.30 (+0.61%)
     
  • Bitcoin

    64,294.97
    +531.21 (+0.83%)
     
  • CMC Crypto 200

    1,386.01
    -10.52 (-0.75%)
     

Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years

Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years

Shares of AstraZeneca (NASDAQ: AZN) and Merck (NYSE: MRK) have both more than doubled over the last five years. With a $228 billion market capitalization, AstraZeneca is the sixth-largest pharmaceutical company in the world and the second-biggest international-based drugmaker behind Novartis (NYSE: NVS). As you'd guess would be the case for a major player in the pharmaceutical industry, the British drugmaker possesses a remarkable product portfolio.